Foscarnet Therapy for Pure Red Cell Aplasia Related to Human Parvovirus B19 Infection in Kidney Transplant Recipients: A Preliminary Exploration
Yedong Yu,1 Ruijie Bao,1 Junhao Lyu,1– 4 Jianyong Wu,1– 4 Jianghua Chen,1– 4 Wenhan Peng1– 4 1Department of Kidney Disease Center, The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, People’s Republic of China; 2Department of Kidney Disease Immunology Laboratory, State Ad...
Main Authors: | Yu Y, Bao R, Lyu J, Wu J, Chen J, Peng W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/foscarnet-therapy-for-pure-red-cell-aplasia-related-to-human-parvoviru-peer-reviewed-fulltext-article-IDR |
Similar Items
-
THE PURE RED BLOOD CELL APLASIA IN RENAL TRANSPLANT RECIPIENT
by: B. T. Dzumabaeva, et al.
Published: (2011-06-01) -
Acquired Pure Red Cell Aplasia caused by Parvovirus B19 Infection following a Renal Transplant
by: Arundathi Kurukulasuriya, et al.
Published: (2011-08-01) -
Pure Red Cell Aplasia Associated with Good Syndrome
by: Masayuki Okui, et al.
Published: (2017-04-01) -
Pure red cell aplasia in a simultaneous pancreas-kidney transplantation patient: inside the erythroblast
by: Francesca Labbadia, et al.
Published: (2012-09-01) -
Acquired pure red cell aplasia and recombinant erythropoietin
by: Somanath Padhi, et al.
Published: (2021-01-01)